These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

615 related articles for article (PubMed ID: 32234138)

  • 41. Public finance of universal routine childhood immunization in India: district-level cost estimates.
    Schueller E; Nandi A; Summan A; Chatterjee S; Ray A; Haldar P; Laxminarayan R
    Health Policy Plan; 2022 Feb; 37(2):200-208. PubMed ID: 34522955
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Infant vaccination timing: Beyond traditional coverage metrics for maximizing impact of vaccine programs, an example from southern Nepal.
    Hughes MM; Katz J; Englund JA; Khatry SK; Shrestha L; LeClerq SC; Steinhoff M; Tielsch JM
    Vaccine; 2016 Feb; 34(7):933-41. PubMed ID: 26788880
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Vaccination coverage in young children and school children in the Bern canton].
    Maurer AM; Seiler AJ
    Soz Praventivmed; 1997; 42(6):324-31. PubMed ID: 9499463
    [TBL] [Abstract][Full Text] [Related]  

  • 44. How do physicians immunize their own children? Differences among pediatricians and nonpediatricians.
    Posfay-Barbe KM; Heininger U; Aebi C; Desgrandchamps D; Vaudaux B; Siegrist CA
    Pediatrics; 2005 Nov; 116(5):e623-33. PubMed ID: 16263976
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adherence to pneumococcal conjugate vaccination schedule and uptake rate as compared to the established diphtheria-tetanus-acellular pertussis vaccination in Cyprus.
    Hadjipanayis A; Efstathiou E; Michaelidou K; Papaevangelou V
    Vaccine; 2018 Sep; 36(38):5685-5691. PubMed ID: 30115523
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Global routine vaccination coverage, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Oct; 59(42):1367-71. PubMed ID: 21030941
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Timeliness of routine immunization in a population-based Italian cohort of very preterm infants: results of the ACTION follow-up project.
    Tozzi AE; Piga S; Corchia C; Di Lallo D; Carnielli V; Chiandotto V; Fertz MC; Miniaci S; Rusconi F; Cuttini M
    Vaccine; 2014 Feb; 32(7):793-9. PubMed ID: 24397902
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK.
    Marlow R; Kuriyakose S; Mesaros N; Han HH; Tomlinson R; Faust SN; Snape MD; Pollard AJ; Finn A
    Vaccine; 2018 Apr; 36(17):2300-2306. PubMed ID: 29576304
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Global Routine Vaccination Coverage, 2018.
    Peck M; Gacic-Dobo M; Diallo MS; Nedelec Y; Sodha SV; Wallace AS
    MMWR Morb Mortal Wkly Rep; 2019 Oct; 68(42):937-942. PubMed ID: 31647786
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunization coverage, knowledge, satisfaction, and associated factors of non-National Immunization Program vaccines among migrant and left-behind families in China: evidence from Zhejiang and Henan provinces.
    Zhou Y; Li D; Cao Y; Lai F; Wang Y; Long Q; Zhang Z; An C; Xu X
    Infect Dis Poverty; 2023 Oct; 12(1):93. PubMed ID: 37833775
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adverse events associated with childhood vaccines other than pertussis and rubella. Summary of a report from the Institute of Medicine.
    Stratton KR; Howe CJ; Johnston RB
    JAMA; 1994 May; 271(20):1602-5. PubMed ID: 8182813
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vaccine adverse events reported in post-marketing study of the Kitasato Institute from 1994 to 2004.
    Nakayama T; Onoda K
    Vaccine; 2007 Jan; 25(3):570-6. PubMed ID: 16945455
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adverse events following immunization with pentavalent vaccine: experiences of newly introduced vaccine in Iran.
    Karami M; Ameri P; Bathaei J; Berangi Z; Pashaei T; Zahiri A; Zahraei SM; Erfani H; Ponnet K
    BMC Immunol; 2017 Aug; 18(1):42. PubMed ID: 28835207
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Preliminary practice of multidisciplinary cooperative vaccination management model for pediatric patients with hematological and oncological diseases].
    Ruan HS; Gao YJ; Fei Y; Cao Q; Chen WJ; Chen J; Zhang H; Wang XW; He MX; Zhou F
    Zhonghua Er Ke Za Zhi; 2021 Apr; 59(4):305-310. PubMed ID: 33775050
    [No Abstract]   [Full Text] [Related]  

  • 55. Coverage of recommended vaccines in children at 7-8 years of age in Flanders, Belgium.
    Theeten H; Vandermeulen C; Roelants M; Hoppenbrouwers K; Depoorter AM; Van Damme P
    Acta Paediatr; 2009 Aug; 98(8):1307-12. PubMed ID: 19432835
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Determinants of vaccination coverage in rural Nigeria.
    Odusanya OO; Alufohai EF; Meurice FP; Ahonkhai VI
    BMC Public Health; 2008 Nov; 8():381. PubMed ID: 18986544
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Factors affecting immunization coverage levels in a district of India.
    Balraj V; Mukundan S; Samuel R; John TJ
    Int J Epidemiol; 1993 Dec; 22(6):1146-53. PubMed ID: 8144298
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hepatitis B vaccination among children in inner-city public housing, 1991-1997.
    Lauderdale DS; Oram RJ; Goldstein KP; Daum RS
    JAMA; 1999 Nov; 282(18):1725-30. PubMed ID: 10568644
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Seroprevalence and vaccination coverage of vaccine-preventable diseases in perinatally HIV-1-infected patients.
    Sticchi L; Bruzzone B; Caligiuri P; Rappazzo E; Lo Casto M; De Hoffer L; Gustinetti G; Viscoli C; Di Biagio A
    Hum Vaccin Immunother; 2015; 11(1):263-9. PubMed ID: 25483544
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Infant immunization coverage in Italy (2000-2016).
    Signorelli C; Odone A; Cella P; Iannazzo S; D'Ancona F; Guerra R
    Ann Ist Super Sanita; 2017; 53(3):231-237. PubMed ID: 28956803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.